Literature DB >> 26806256

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study.

E Munier-Marion1, T Bénet2, C Régis1, B Lina3, F Morfin3, P Vanhems4.   

Abstract

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza were assessed prospectively. The incidence was 2.0 for 100 patient-days in double- vs. 0.7 in single-occupancy rooms (p 0.028). The adjusted hazard ratio of hospital-acquired influenza was 2.67 (95% confidence interval 1.05-6.76) in patients hospitalized in double- compared to single-occupancy rooms.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cohort; double-occupancy room; epidemiology; hospital-acquired infection; influenza

Mesh:

Year:  2016        PMID: 26806256     DOI: 10.1016/j.cmi.2016.01.010

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  System dynamic modelling of healthcare associated influenza -a tool for infection control.

Authors:  Martina Sansone; Paul Holmstrom; Stefan Hallberg; Rickard Nordén; Lars-Magnus Andersson; Johan Westin
Journal:  BMC Health Serv Res       Date:  2022-05-27       Impact factor: 2.908

2.  Building an Intelligent Hospital to Fight Contagion.

Authors:  Jérôme Bataille; Philippe Brouqui
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

3.  Hospital-acquired influenza infections detected by a surveillance system over six seasons, from 2010/2011 to 2015/2016.

Authors:  P Godoy; N Torner; N Soldevila; C Rius; M Jane; A Martínez; J A Caylà; A Domínguez
Journal:  BMC Infect Dis       Date:  2020-01-28       Impact factor: 3.090

4.  Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project.

Authors:  Mitra Saadatian-Elahi; Valentina Picot; Laetitia Hénaff; Florence K Pradel; Vanessa Escuret; Cédric Dananché; Christelle Elias; Hubert P Endtz; Philippe Vanhems
Journal:  BMJ Open       Date:  2020-10-22       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.